Cardiovascular effects of E4080, a novel bradycardiac agent with coronary vasodilating properties, in anesthetized dogs
- 22 October 1991
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 203 (3) , 399-404
- https://doi.org/10.1016/0014-2999(91)90897-y
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Vasodilating effects of E4080 in isolated vascular smooth muscles: comparison with cromakalim and verapamilEuropean Journal of Pharmacology, 1990
- Coronary vasodiiating and bradycardic actions of E4080 in conscious dogsEuropean Journal of Pharmacology, 1990
- Moving together: K+ channel openersand ATP-sensitive K+ channelsTrends in Pharmacological Sciences, 1989
- Cromakalim, a Potassium Channel ActivatorJournal of Cardiovascular Pharmacology, 1988
- Similarities in the Mechanism of Action of Two New Vasodilator Drugs: Pinacidil and BRL 34915Journal of Cardiovascular Pharmacology, 1988
- Cardiovascular characterisation of UL-FS 49,1,3,4,5-tetrahydro-7,8-dimethoxy-3-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylimino]propyl]-2H-3-benzazepin- 2-on hydrochloride, a new “specific bradycardic agent”European Journal of Pharmacology, 1984
- AQ-A 39 (5,6-dimethoxy-2-[3[[α-(3,4-dimethoxy)-phenyl-ethyl]methylamino]propyl]phtalimidine), a specific bradycardic agent with direct action on the heartEuropean Journal of Pharmacology, 1981
- Cardiovascular actions of N-allyl-clonidine (ST 567), a substance with specific bradycardic actionEuropean Journal of Pharmacology, 1979
- Prostaglandins and the control of blood flow in the canine myocardium.Circulation Research, 1977
- New Tables for Multiple Comparisons with a ControlPublished by JSTOR ,1964